Detalhe da pesquisa
1.
Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy.
Transpl Int
; 35: 10228, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35497889
2.
Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use.
J Am Soc Nephrol
; 30(7): 1206-1219, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227636
3.
Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients.
Clin Kidney J
; 14(8): 1908-1914, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34345414